abs107.txt	although	patient-reported	outcomes	(pros)		such	as	health-related	quality	oflife	are	important	endpoints	in	randomised	controlled	trials	(rcts)	there	islittle	consensus	about	the	analysis	interpretation	and	reporting	of	these	data	we	did	a	systematic	review	to	assess	variability	standards	ofpro	analyses	advanced	breast	cancer	rcts	searched	pubmed	for	englishlanguage	articles	published	peer-reviewed	journals	between	jan	1	2001	andoct	30	2017	eligible	were	those	that	reported	pro	results	from	ofadult	patients	with	receiving	anti-cancer	treatments	withreported	sample	sizes	at	least	50	patients-66	met	selection	criteria	only	eight	(12%)	specific	research	hypothesis	heterogeneityin	statistical	methods	used	was	observed	mixtureof	longitudinal	cross-sectional	techniques	not	all	addressed	theproblem	multiple	testing	fewer	than	half	(28	[42%])	theclinical	significance	their	findings	48	(73%)	report	how	missing	datawere	handled	our	shows	need	improve	theanalysis	lack	ofstandardisation	makes	it	difficult	draw	robust	conclusions	comparefindings	across	setting	international	analyzingpatient-reported	life	consortium	set	up	toaddress	this	develop	recommendations	on	inrcts
